PhotoMedex announces effectiveness of form S-4

MONTGOMERYVILLE, USA: PhotoMedex Inc., a leader in the development of proprietary excimer laser, LED light systems and skin care products for dermatological applications, announced that the Securities and Exchange Commission (SEC) has declared PhotoMedex’ Registration Statement on Form S-4 relating to the previously announced proposed merger between PhotoMedex Inc. and Radiancy Inc., a privately held dermatology device company effective as of 10:00 a.m. on November 22, 2011.

The Registration Statement contains a proxy statement/prospectus, which will be mailed to the stockholders of PhotoMedex as well as Radiancy commencing on or about November 22, 2011, seeking their approval of, among other things, the merger.

In addition to registering the shares of PhotoMedex common stock to be issued to the stockholders of Radiancy in the merger, the Registration Statement includes proxy materials for the annual meeting of the PhotoMedex shareholders, which will be held at 9:30 a.m. Eastern Time, on Monday, December 12, 2011, at the offices of Kaye Scholer LLP, located at 425 Park Avenue, New York, NY 10022 and the special meeting of the Radiancy stockholders, which will be held at 10:00 a.m. Eastern Time, on Monday, December 12, 2011, at the offices of Ellenoff Grossman & Schole LLP, located at 150 East 42nd Street, 11th Floor, New York, NY 10017.

The consummation of the merger is subject to the approval of the merger by Radiancy’s stockholders and PhotoMedex’s stockholders as well as other customary closing conditions. The boards of directors of PhotoMedex and Radiancy have approved the transaction. The majority of Radiancy stockholders and stockholders representing approximately 46 percent of the common stock of PhotoMedex have agreed to vote their shares in favor of the merger.